American Association for Cancer Research
Browse

Figure 2 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin

Download (498.34 kB)
figure
posted on 2025-07-02, 07:22 authored by Joanna Domagala, Tomasz M. Grzywa, Iwona Baranowska, Magdalena Justyniarska, Ryan Tannir, Agnieszka Graczyk-Jarzynka, Aleksandra Kusowska, Maria Lecka, Marcin Poreba, Klaudyna Fidyt, Katsiaryna Marhelava, Zofia Pilch, Lea K. Picard, Tomasz Wegierski, Kamil Jastrzebski, Marta Krawczyk, Marta Klopotowska, Monika Granica, Doris Urlaub, Szymon Hajduk, Alexandra Neeser, Spencer Moros, Pawel Kozlowski, Malgorzata Bobrowicz, Marta Miaczynska, Leyuan Ma, Carsten Watzl, Magdalena Winiarska
<p>Ammonia concentration is increased in cancer cell–conditioned medium and TIF. Ammonia concentration in the tumor-conditioned medium, collected after 48 hours of incubation, was measured using a Dimension Ammonia assay (Siemens; <i>n</i> = 3). Cells were cultured at different densities: lymphoma (0.5 × 10<sup>6</sup>, 1.0 × 10<sup>6</sup>, 1.5 × 10<sup>6</sup>/mL; <b>A</b>), multiple myeloma (1 × 10<sup>6</sup>, 2 × 10<sup>6</sup>, 4 × 10<sup>6</sup>/mL; <b>B</b>), and breast cancer cell lines (0.5 × 10<sup>6</sup>, 1 × 10<sup>6</sup>, 1.5 × 10<sup>6</sup>/mL; <b>C</b>). In <b>A–C</b>, empty medium incubated for 48 hours (without the cells) at 4°C or 37°C is presented as a control. <b>D,</b> Schematic presentation of the TIF and SCF isolation from mice. TIF was collected from tumors not exceeding 1,500 mm<sup>3</sup>. SCF was isolated at the same time from the contralateral tight as a control tissue fluid. <b>E–G,</b> The concentration of ammonia in TIF and SCF isolated from Raji tumor–bearing NSG (<i>n</i> = 5; <b>E</b>), MM.1s tumor–bearing SCID mice (<i>n</i> = 5; <b>F</b>), and breast cancer–bearing mice (EMT6 in BALB/c mice, <i>n</i> = 5; E0771 in BALB/c mice, <i>n</i> = 5; 4T1 in BALB/c mice; <i>n</i> = 5; MCF7 in NSG mice, <i>n</i> = 4; MDA-MB-231 in NSG mice, <i>n</i> = 3; <b>G</b>). <i>P</i> values were calculated using a paired <i>t</i> test. Data show individual values and means ± SEM. <i>n</i> values are the number of biological replicates in <i>in vitro</i> experiments or the number of mice used to obtain the data. <b>D,</b> Created with BioRender.com. Winiarska, M. (2025) <a href="https://BioRender.com/x56a982" target="_blank">https://BioRender.com/x56a982</a>.</p>

Funding

HORIZON EUROPE European Research Council (ERC)

Narodowe Centrum Badań i Rozwoju (NCBR)

Narodowe Centrum Nauki (NCN)

NextGenerationEU (NGEU)

Fundacja na rzecz Nauki Polskiej (FNP)

Ministerstwo Edukacji i Nauki (MNiSW)

Melanoma Research Alliance (MRA)

Sontag Foundation (The Sontag Foundation)

History

ARTICLE ABSTRACT

Immunotherapy revolutionized cancer treatment in the last decade. Both NK cells and T cells are key components of host immunity against malignant cells that are being extensively investigated in the field of cancer immunotherapy. While approaches have been developed to improve the antitumor activity of NK and T cells, the tumor microenvironment remains an obstacle to effective NK and T‐cell–based therapies. Here, we demonstrated that cancer‐conditioned medium suppresses the antitumor activity of NK cells. Ammonia, a by‐product of cancer cell metabolism, accumulated in cancer‐conditioned medium and in the tumor microenvironment, and impaired the cytotoxicity of NK cells as well as the efficacy of antibody‐based and chimeric antigen receptor (CAR) NK and CAR T‐cell–based therapies in vitro. Ammonia induced NK and T‐cell dysfunction by decreasing the amount of mature perforin in secretory lysosomes, which was dependent on its lysosomotropic features and ability to increase pH in acidic compartments. These findings demonstrate that, in addition to its previously described role in promoting tumor growth as a source of nitrogen for tumor biomass, ammonia promotes tumor immune escape by inhibiting both NK and CAR T‐cell cytotoxicity. Ammonia is elevated in the tumor microenvironment and functions as an immunoinhibitory metabolite in cancer by reducing perforin levels, inhibiting NK and T‐cell–mediated immunity and limiting the efficacy of immunotherapies.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC